Effectiveness of Manual Therapy in the Treatment of Attention Deficit Hyperactivity Disorder
Launched by JJ JIMENEZ-REJANO · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether adding Manual Therapy—a hands-on treatment that involves gentle movements and techniques on the body—can help improve symptoms of Attention Deficit Hyperactivity Disorder (ADHD) better than the usual treatments alone. The study aims to find out if this extra therapy can make a meaningful difference for children and teenagers with ADHD.
Children and adolescents between the ages of 6 and 12 who have been officially diagnosed with ADHD and whose parents or guardians agree to the treatment may be eligible to join. Participants will need to attend all the Manual Therapy sessions as part of the study. However, children with certain serious medical or mental health conditions, or those who have recently changed their ADHD medications, won’t be able to take part. This trial is not yet recruiting participants, but it offers a new approach to see if combining therapies can better support kids managing ADHD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed ADHD diagnosis according to DSM-5 criteria.
- • Children and adolescents aged 6 to 12 years.
- • Availability to attend all Manual Therapy (MT) sessions.
- • Informed consent signed by legal guardians.
- Exclusion Criteria:
- • Severe concomitant psychiatric or neurological disorders (e.g., epilepsy, severe autism spectrum disorder, schizophrenia).
- • Medical conditions that contraindicate MT (e.g., fractures, severe scoliosis, connective tissue diseases).
- • Recent use of or changes in ADHD medication within the past 4 weeks.
- • Simultaneous participation in other interventional studies.
About Jj Jimenez Rejano
JJ Jimenez-Rejano is a clinical trial sponsor dedicated to advancing medical research through rigorous and ethical study designs. Committed to improving patient outcomes, the sponsor collaborates with healthcare professionals and research institutions to conduct high-quality clinical investigations across various therapeutic areas. Their focus on innovation and scientific integrity supports the development of effective and safe medical treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcalá De Henares, Madrid, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported